Dynamic Technology Lab Private LTD Xenon Pharmaceuticals Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $320,113 - $372,309	9,371 New	9,371 $320,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $307,592 - $397,801	9,990 New	9,990 $361,000
Q2 2022 Aug 12, 2022	SELL	$25.44 - $35.16 $355,981 - $491,993	-13,993 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $351,084 - $463,588	13,993 New	13,993 $428,000
Q2 2020 Aug 14, 2020	SELL	$10.21 - $14.9 $138,233 - $201,731	-13,539 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$8.08 - $17.57 $109,395 - $237,880	13,539 New	13,539 $154,000
Q3 2017 Nov 08, 2017	SELL	$2.45 - $3.25 $31,852 - $42,253	-13,001 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	13,001	13,001 $41,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.